In his new role, Dr Moerck will lead Valensa’s move into the next generation of high-performance plant-derived dietary supplements and functional food ingredients, which includes Valensa’s ‘direct to marketers’ product development and business strategy.
Dr Moerck will lead Valensa’s new management team that includes executives from both Valensa and Parry. Prior to joining Valensa, Dr Moerck was president of Altair Nanotechnologies.
Dr Moerck said: “We feel that our strategy at Valensa – to use the most scientifically important natural materials, to use the best technology and quality control, to optimize the product forms in terms of stability and efficacy, and to create compelling messages around our products – will position us as a ‘next generation’ leader to the industry and the consumer.”